WallStreetZenWallStreetZen

NYSEMKT: AIM
Aim Immunotech Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

AIM past revenue growth

How has AIM's revenue growth performed historically?
Company
15.07%
Industry
101.17%
Market
13.81%
AIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AIM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AIM earnings and revenue history

Current Revenue
$168.0k
Current Earnings
-$19.3M
Current Profit Margin
-11,514.3%

AIM Return on Equity

Current Company
-52.9%
Current Industry
1.3%
Current Market
22.1%
AIM's Return on Equity (-52.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AIM announces earnings.

AIM Return on Assets

Current Company
-49%
Current Industry
-1.3%
AIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AIM Return on Capital Employed

Current Company
-62.94%
Current Industry
12.1%
AIM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AIM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AIM$168.00k-$19.02M-$19.34M-6.01%N/A
INDP$0.00-$14.62M-$14.62MN/AN/A
ALZN$0.00-$15.33M-$15.37MN/AN/A
GNPX$0.00-$30.01M-$30.03MN/AN/A
PPBT$0.00$21.23M$20.85M-100.00%N/A
View Top Biotech Stocks

AIM earnings dates

Next earnings date
Nov 13, 2023

Aim Immunotech Earnings & Revenue FAQ

What were AIM's earnings last quarter?

On Invalid Date, Aim Immunotech (NYSEMKT: AIM) reported Q2 2023 earnings per share (EPS) of -$0.10, up 0% year over year. Total Aim Immunotech earnings for the quarter were -$4.91 million. In the same quarter last year, Aim Immunotech's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Aim Immunotech stock.

What was AIM's earnings growth in the past year?

As of Q3 2023, Aim Immunotech's earnings has grown year over year. Aim Immunotech's earnings in the past year totalled -$19.34 million.

What is AIM's earnings date?

Aim Immunotech's earnings date is Invalid Date. Add AIM to your watchlist to be reminded of AIM's next earnings announcement.

What was AIM's revenue last quarter?

On Invalid Date, Aim Immunotech (NYSEMKT: AIM) reported Q2 2023 revenue of $42.00 thousand up 40% year over year. In the same quarter last year, Aim Immunotech's revenue was $30.00 thousand.

What was AIM's revenue growth in the past year?

As of Q3 2023, Aim Immunotech's revenue has grown 15.07% year over year. This is 86.1 percentage points lower than the US Biotechnology industry revenue growth rate of 101.17%. Aim Immunotech's revenue in the past year totalled $168.00 thousand.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.